Company Name:UroGen Pharma Ltd.
CEO:

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.


Key numbers

Market Capitalization:557438600
Shares Outstanding: 20980000
Float: 17093224.22
Next Earning Date:2020-02-25
TTm EPS: -4.7144
TTm Dividend Rate:
200 days moving average:33.54
50 days moving average: 25.94
One day percent Change: 20.94



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,